85. Idiopathic interstitial pneumonia Clinical trials / Disease details
Clinical trials : 598 / Drugs : 435 - (DrugBank : 116) / Drug target genes : 100 - Drug target pathways : 210
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02268981 (ClinicalTrials.gov) | September 2014 | 17/9/2014 | Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) | Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) | Idiopathic Pulmonary Fibrosis | Device: Oxymizer® compared to CNC | Klinikum Berchtesgadener Land der Schön-Kliniken | NULL | Completed | 30 Years | 80 Years | Both | 18 | N/A | Germany |